A novel pyrazoloacridone compound, KW-2170, in human cancer cell lines: The cellular sensitivity determinants and the synergistic combination.

被引：0
|
作者：
Sekikawa, T
Takano, H
Yamamoto, W
Nishiyama, M
机构：
[1] Hiroshima Univ, Res Inst Rad Biol Med, Dept Biochem Biophys, Hiroshima, Japan
[2] Showa Univ, Toyosu Hosp, Dept Internal Med, Tokyo, Japan
来源：
CLINICAL CANCER RESEARCH | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
482
引用
收藏
页码：4563S / 4563S
页数：1
相关论文
共 47 条
  • [21] Novel naproxen, resveratrol and sulforaphane (NRS) combinations demonstrate synergistic decrease in cell viability of human colon and pancreatic cancer cell lines
    Grandhi, B. Karthik
    Thakkar, Arvind
    Prabhu, Sunil
    CANCER RESEARCH, 2012, 72
  • [22] In vitro sensitivity of human endometrial cancer cell lines to paclitaxel or irinotecan (CPT-11) in combination with other aniticancer drugs
    Hiramatsu, HP
    Kikuchi, Y
    Seto, H
    Nagata, I
    ANTI-CANCER DRUGS, 2000, 11 (07) : 573 - 578
  • [23] Synergistic activity of the novel apoptosis-inducing compound KP1339 with the tyrosine kinase inhibitor sorafenib in cancer cell lines of diverse origin
    Heffeter, P.
    Atil, B.
    Jungwirth, U.
    Gal, E.
    Gojo, J.
    Micksche, M.
    Keppler, B. K.
    Berger, W.
    EJC SUPPLEMENTS, 2010, 8 (07): : 63 - 63
  • [24] Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds
    Fujiki, Hirota
    Sueoka, Eisaburo
    Watanabe, Tatsuro
    Suganuma, Masami
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (09) : 1511 - 1522
  • [25] Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds
    Hirota Fujiki
    Eisaburo Sueoka
    Tatsuro Watanabe
    Masami Suganuma
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1511 - 1522
  • [26] PM01183 is a novel compound that binds DNA and displays cytotoxic effect in vitro and in vivo in human cancer cell lines
    Moneo, Victoria
    Martinez-Leal, Juan
    Jose Guillen, Maria
    Martinez, Patricia
    Tarazona, Guillermo
    Aviles, Pablo
    Cuevas, Carmen
    Garcia-Fernandez, Luis
    Galmarini, Carlos
    CANCER RESEARCH, 2009, 69
  • [27] Molecular and cellular effects of AP5346, a novel DACH-platinum linked polymer-compound, compared to oxaliplatin and cisplatin in a panel of human cancer cell lines.
    Serova, Maria
    Aissat, Nasredine
    Ghoul, Aida
    Rezai, Keyvan
    Bieche, Ivan
    Vidaud, Michel
    Szyldergemajn, Sergio
    Nowotnik, David
    Lokiec, Francois
    Faivre, Sandrine
    Raymond, Eric
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3560S - 3560S
  • [28] Finding novel chemical compounds with selective cytotoxic activity on human cancer cell lines using automated cellular imaging.
    Santiago-Vazquez, Y.
    Lema, C.
    Varela-Ramirez, A.
    Aguilera, R. J.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [29] SENSITIVITY TO NOVEL PLATINUM COMPOUNDS OF PANELS OF HUMAN LUNG-CANCER CELL-LINES WITH ACQUIRED AND INHERENT RESISTANCE TO CISPLATIN
    TWENTYMAN, PR
    WRIGHT, KA
    MISTRY, P
    KELLAND, LR
    MURRER, BA
    CANCER RESEARCH, 1992, 52 (20) : 5674 - 5680
  • [30] Synergistic antitumor activity of the combination of the multi-targeted tyrosine kinase inhibitor sorafenib and of EGFR inhibitors in human colon and lung cancer cell lines
    Martinelli, E.
    Troiani, T.
    Laus, G.
    Pepe, S.
    Ciardiello, F.
    EJC SUPPLEMENTS, 2006, 4 (12): : 123 - 123
12345